Holen Sie sich die Stockscreener-App
1.80
2.70%
-0.05
Handel nachbörslich:
1.80
Schlusskurs vom Vortag:
$1.85
Offen:
$1.85
24-Stunden-Volumen:
36,520
Relative Volume:
0.59
Marktkapitalisierung:
$45.08M
Einnahmen:
$12.00M
Nettoeinkommen (Verlust:
$-63.23M
KGV:
-0.2287
EPS:
-7.87
Netto-Cashflow:
$-43.02M
1W Leistung:
-5.76%
1M Leistung:
-0.55%
6M Leistung:
+104.08%
1J Leistung:
-64.71%
1-Tages-Spanne:
$1.76
$1.86
1-Wochen-Bereich:
$1.76
$1.9909
52-Wochen-Spanne:
$0.73
$5.405
Accelerate Diagnostics Inc Stock (AXDX) Company Profile
Firmenname
Accelerate Diagnostics Inc
Sektor
Branche
Telefon
303-863-8088
Adresse
3950 S. COUNTRY CLUB ROAD #470, TUCSON, AZ
Vergleichen Sie AXDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| AXDX | 1.80 | 45.08M | 12.00M | -63.23M | -43.02M | -7.87 |
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Accelerate Diagnostics Inc Stock (AXDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-03-09 | Herabstufung | Craig Hallum | Buy → Hold |
| 2020-10-08 | Eingeleitet | BTIG Research | Neutral |
| 2020-08-07 | Hochstufung | Craig Hallum | Hold → Buy |
| 2019-09-27 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-11-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-05-24 | Eingeleitet | Craig Hallum | Hold |
| 2017-12-13 | Herabstufung | BTIG Research | Buy → Neutral |
| 2017-07-12 | Fortgesetzt | BTIG Research | Buy |
| 2016-03-24 | Eingeleitet | JP Morgan | Overweight |
| 2015-12-16 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Accelerate Diagnostics Inc Aktie (AXDX) Neueste Nachrichten
Accelerate Diagnostics (NASDAQ:AXDX) Raised to “Hold” at StockNews.com - Defense World
William Blair Has Bearish Estimate for AXDX FY2024 Earnings - Defense World
Armistice Capital, LLC's Strategic Acquisition in Accelerate Dia - GuruFocus.com
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q3 2024 Earnings Call Transcript - Insider Monkey
Accelerate Diagnostics (AXDX) Reports Q3 Loss, Lags Revenue Estimates - MSN
Accelerate Diagnostics: Q3 Earnings Snapshot - Houston Chronicle
Accelerate Diagnostics Reports Key Advances Amid Financial Challenges - TipRanks
Accelerate Diagnostics Reports Third Quarter 2024 Financial Results - StockTitan
Antimicrobial Susceptibility Testing Market is Expected to Soar in the Upcoming Years - openPR
Accelerate Diagnostics (NASDAQ:AXDX) Earns Sell Rating from Analysts at StockNews.com - Defense World
BeeKeeperAI, Topcon Healthcare Collaborating on Optical Diagnostics - MPO-mag
BNGOBionano Genomics, Inc. Latest Stock News & Market Updates - StockTitan
Blue Earth Therapeutics Ltd announces completion of $76.5M Series A financing to accelerate development of next generation targeted radioligand therapies - PR Newswire
StockNews.com Begins Coverage on Accelerate Diagnostics (NASDAQ:AXDX) - Defense World
AXDXAccelerate Diagnostics, Inc. Latest Stock News & Market Updates - StockTitan
Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results - Kilgore News Herald
Accelerate Diagnostics (NASDAQ:AXDX) Earns Hold Rating from Analysts at StockNews.com - Defense World
Comparing Accelerate Diagnostics (NASDAQ:AXDX) & Advanced BioMedical Technologies (OTCMKTS:ABMT) - Defense World
Antimicrobial Resistance Diagnostics Market to Witness an Outstanding Growth by 2032 - openPR
Antibiotic Sensitivity Testing Market Growth and Industry Overview - News in Assen
Accelerate Diagnostics (NASDAQ:AXDX) Research Coverage Started at StockNews.com - Defense World
Optical Imaging Market Size to Reach USD 5.61 Billion by 2033 | Straits Research - GlobeNewswire
Cytovale Completes $100 Million Series D Funding to Accelerate Commercial Expansion of its Rapid Sepsis Solution - PR Newswire
Saudi Arabia Diagnostic Imaging Market Will Accelerate Rapidly - openPR
Accelerate Diagnostics Stock Down Despite FDA Clearance for Arc System - Yahoo Finance
FDA approves Accelerate Arc system to identify microbial infections - Medical Device Network
FDA clears new system for rapid sepsis identification By Investing.com - Investing.com Australia
FDA clears new system for rapid sepsis identification - Investing.com
Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System - StockTitan
Short Interest in Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Drops By 12.6% - Defense World
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Stake Reduced by Armistice Capital LLC - Defense World
StockNews.com Initiates Coverage on Accelerate Diagnostics (NASDAQ:AXDX) - Defense World
Italy Antimicrobial Resistance Diagnostics Market Size & Outlook, 2030 - Grand View Research
North America Antimicrobial Resistance Diagnostics Market Size & Outlook, 2030 - Grand View Research
PersonalAIze and Cube Forge Groundbreaking Partnership to - GlobeNewswire
PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics - Yahoo Finance
Accelerate Diagnostics (NASDAQ:AXDX) Stock Crosses Above 200 Day Moving Average of $1.21 - Defense World
Veterinary Antimicrobial Susceptibility Testing Market: In-depth Analysis Of Market Trends, Technological A... - WhaTech
Blood Screening Market Advancements Highlighted by Size, Share, Growth Analysis, Business Insights And Fore... - WhaTech
Europe Point Of Care TB And Drug-resistant TB Testing Market | Report, 2030 - Grand View Research
North America Antibiotic Sensitivity Testing Market By Application - Third Eye News
RenovaroCube to Present Cutting-Edge Cancer Diagnostics - GlobeNewswire
Agilent Unveils Biopharma CDx Services Lab to Accelerate Precision Medicine - Business Wire
Chlamydia Infection Diagnostics And Therapeutics Global Market 2024Latest Trends, Technological Advancem... - WhaTech
Blood Culture Tests Market 2024: Pioneering Innovations in Diagnostic Healthcare As Discussed In New Market... - WhaTech Technology and Markets News
New Release of Ibex Medical Analytics AI-powered Platform to Accelerate Advancements in Cancer Diagnostics - Business Wire
India Antimicrobial Resistance Diagnostics Market Size & Outlook, 2030 - Grand View Research
In Vitro Diagnostics Market Trends 2024-2033: Overview, Share, Demand, and Outlook - WhaTech
Accelerate Diagnostics (NASDAQ:AXDX) Coverage Initiated by Analysts at StockNews.com - Defense World
Emerging Trends and Opportunities in the Antimicrobial Susceptibility Testing Market - openPR
Finanzdaten der Accelerate Diagnostics Inc-Aktie (AXDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):